Literature DB >> 15808238

Discovery of ligands by a combination of computational and NMR-based screening: RNA as an example target.

Moriz Mayer1, Thomas L James.   

Abstract

NMR for screening of knowledge-based focused libraries of compounds provides an efficient, cost-effective method to develop promising drug leads that target functionally important RNA structures. A knowledge-based focused library may be constructed from virtual (i.e., computational) screening of commercial or proprietary databases of available compounds for binding to the three-dimensional structure of a selected RNA target. Alternatively, the library may be constructed from compounds with properties deemed desirable, e.g., molecular moiety commonly found in drugs or known to bind RNA. The library ideally should be composed of small water-soluble, nonpeptide, nonnucleotide organic compounds. Various simple, robust NMR experiments are described that enable experimental screening of such a library for binding to a selected RNA structure. Some of the NMR experiments enable rapid mapping of the interaction site on the RNA to verify that the targeted structure is hit rather than the double helical region or a commonly occurring tetraloop. Other experiments enable elucidation of the ligand's binding moiety. Of course, any compounds thus identified should represent promising scaffolds suitable for easy chemical modification to enhance their pharmaceutical properties for subsequent drug development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808238     DOI: 10.1016/S0076-6879(05)94024-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

Review 1.  RNA Structural Differentiation: Opportunities with Pattern Recognition.

Authors:  Christopher S Eubanks; Amanda E Hargrove
Journal:  Biochemistry       Date:  2018-12-18       Impact factor: 3.162

2.  DOCK 6: combining techniques to model RNA-small molecule complexes.

Authors:  P Therese Lang; Scott R Brozell; Sudipto Mukherjee; Eric F Pettersen; Elaine C Meng; Veena Thomas; Robert C Rizzo; David A Case; Thomas L James; Irwin D Kuntz
Journal:  RNA       Date:  2009-04-15       Impact factor: 4.942

3.  Identification and validation of a novel anti-virulent that binds to pyoverdine and inhibits its function.

Authors:  Xu Wang; Quinn Kleerekoper; Alexey V Revtovich; Donghoon Kang; Natalia V Kirienko
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.